Protagonist Therapeutics, Inc. (PTGX) Earnings Per Share (EPS)
Protagonist Therapeutics, Inc. (PTGX) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | -$2.98 |
| 2020-12-31 | -$1.92 |
| 2021-12-31 | -$2.71 |
| 2022-12-31 | -$2.60 |
| 2023-12-31 | -$1.39 |
| 2024-12-31 | $4.47 |
| 2025-12-31 | -$2.05 |
How PTGX compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| ATRC | AtriCure Inc. | -$0.24 |
| ALDX | Aldeyra Therapeutics Inc. | -$0.56 |
| BKD | Brookdale Senior Living Inc. | -$1.12 |
| BAX | Baxter International Inc. | -$1.87 |
| VTRS | Viatris Inc. | -$3.00 |
These are five companies in the same sector as PTGX with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Protagonist Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("PTGX")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PTGX | $155.10 | +0.00% | 0.44M |
| 3 | ||||
| 4 | ||||
| 5 |